Table 1.

Mechanical properties, measured in terms of compliance and burst pressure, and structural properties, measured in terms of wall thickness, inner diameter, and vessel wall thickness-to-radius (T:R) ratio, from a selection of studies concerning native tissue, synthetic grafts, in vitro tissue-engineered grafts, and in situ tissue-engineered grafts. Compliance is measured in the physiological range, i.e., 80–120 mmHg, unless indicated otherwise.

Artery	Material	Design	Model	Compliance (%/100 mmHg)	Burst Pressure (mmHg)	Thickness ($\mathsf{\mu }$m)	Inner Diameter (mm)	T:R (-)	Ref.
Native	AA	n.a.	rat	6.7	3415	150	1	0.3	[13]
	CA	n.a.	porcine	18.7 *	3320	614	n.d.	n.d.	[14]
	IMA	n.a.	porcine	11.2	2100	231	n.d.	n.d.	[15]
	FA	n.a.	sheep	3.3	2297	770	n.d.	n.d.	[16]
	FA	n.a.	sheep	8.52 †	n.d.	n.d.	n.d.	n.d.	[17]
	CA	n.a.	sheep	11.98	10,950	750	2.25	0.67	[18]
	FA	n.a.	human	2.6	n.d.	n.d.	n.d.	n.d.	[19]
	IMA	n.a.	human	4.5–6.2	2031–4225	350–710	n.d.	n.d.	[9]
	IMA	n.a.	human	11.5	3196	300–800	1.5–4.5	0.35–0.40	[20]
Synthetic	PGA or PLLA + PLCL	non-woven porous graft	n.a.	n.d.	2710–2790	150–250	0.7–0.9	0.33–0.71	[21]
	PCL	e-spun microfibrous graft	n.a.	0.58–0.92	850–1800	415	6	0.14	[22]
	PLLA	e-spun microfibrous graft	n.a.	0.93	n.d.	390	4.9	0.16	[17]
	PLLA/PLCL	bi-layered graft with inner e-spun and outer weft-knitted layer	n.a.	1.8	21,750	330	3.2	0.21	[23]
	PLLA/PHD	bi-layered graft with different blend rations	n.a.	1.12	1775	230	5	0.09	[24]
	PEUU	bi-layered graft with large inner pores and dense outer pores	n.a.	4.6	2300	743	4.7	0.32	[15]
	poly(diol citrate)	non-woven porous graft	n.a.	12.7	250	160	3.65	0.09	[25]
In vitro	PGA	non-woven porous graft	10 weeks under pulsatile conditions	n.d.	1300–1337	442	3	0.29	[26]
	PGA	non-woven porous graft	1 week static, 4 weeks dynamic strain (1%)	n.d.	906	1000	3	0.67	[27]
	human fibroblast sheets	sheet-based	8 weeks static, 10 weeks maturation	1.5	3468	407	4.2	0.19	[9]
	fibrin	fibroblast-seeded fibrin gel	2 weeks static, 5–7 weeks dynamic strain (7%)	2.4–4.4	1366–1542	280–430	2–4	0.22–0.28	[16]
	PGA	non-woven porous graft	7–10 weeks dynamic strain (2.5%)	3.3	3337	1000	6	0.33	[8]
	PGA	non-woven porous graft	7–8 weeks dynamic strain (1.5%)	3.5 *	800	220	3	0.15	[14]
	human fibroblast sheets	sheet-based	6–8 weeks static, 12 weeks maturation	3.54	3490	200–600	2.4–6.6	0.18	[20]
In situ	PCL/CS	e-spun nanofibrous graft	sheep (CA), 6 months	6.58	10,275	1180	2.9	0.81	[18]
	PEOT/BPT/PCL	PEOT/BPT solid rod with external e-spun PCL sheet	porcine (SC), 4 weeks	7.46	3947	700	2	0.70	[10]
	PCL	e-spun nano/microfibrous graft	rat (AA), 1.5–18 months	7.8	3280	650	2	0.65	[28]
	PGS/PCL	porous PGS reinforced with PCL sheet	rat (AA), 3 months	11	2360	290	0.72	0.81	[13]

AA, abdominal artery; CA, carotid artery; FA, femoral artery; IMA, internal mammary artery; PGA, polyglycolic acid; PLLA,poly-L-lactic acid; PLCL, 50:50 copolymer solution of L-lactide and $\epsilon$-caprolactone; PCL, poly(caprolactone); PEUU, poly(esterure-thane)urea; CS, chitosan; PEOT/BPT, poly(ethylene oxide terephthalate)-poly(butylene terephthalate; SC, subcutaneous; PGS, poly(glycerol sebacate); n.a., not applicable; n.d., not determined; *, 80–200 mmHg; ^†, 60–190 mmHg.